The use of LC–MS in early drug discovery: survey


The use of LC–MS in early discovery stage-workflows enables rapid screening of large compound libraries for activity against biological targets. This technique can accelerate the early drug screening process, identifying compounds with potential – known as drug leads – and reduce time spent on discovering inefficient leads. 

To kick start our Spotlight on LC–MS in early drug discovery, we want to know about your experiences and how this field has developed. Click here to complete our short survey in a new tab or fill out the form, below, and enter our prize draw for a chance to win a $25 Amazon voucher!

Complete survey

Create your own user feedback survey